Open Science

      Open Science: An update of the latest results from PMI Science

      We at Philip Morris International have committed to replacing cigarettes with better alternatives as rapidly as possible for adults who would otherwise continue to smoke. In this era of social distancing and online conferences, we’ve created this space to share our scientific results openly with the scientific community.

       

      Due to the success of our Open Science conference series, we have expanded our series to include a wider range of topics. We have described our recent results, explored important details, and explained the fundamental principles behind our research. Most Open Science events are 1-2 hours long and hosted three times throughout the day, so we can reach audiences around the world. 

       

      In August 2022, we were honored to receive a silver Stevie award for Achievement in Science or Technology for our Open Science event series, which has grown from a simple webinar in 2020 to a variety of offerings including live and in-person events.

      Open Science in Brief: A Focus on Real-World Evidence
      Next Event

      Open Science in Brief: A Focus on Real-World Evidence

      Watch Dr. Angela van der Plas, Manager Real-World Evidence & Epidemiology, present some of the data we have gathered based on the real-world evidence around our leading heated tobacco product.

       

      The event was held on September 20th on LinkedIn. Click the link below to watch the recording or browse the video transcript.

      See the event details
      Archive

      Explore all our Open Science events

      We've found that hosting webinars is a great way for us to share our latest results with the scientific community. In case you missed one, check out each of our Open Science events below.

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts to develop and assess products that have the potential to reduce individual risk and population harm associated with tobacco use. This site is for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not for advertising or marketing. It is not intended for use by consumers.

      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. Our RRPs are smoke-free products that produce an aerosol that contains far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.